DK3468553T3 - Andrographolid behandler progressive former for multipel sklerose - Google Patents

Andrographolid behandler progressive former for multipel sklerose Download PDF

Info

Publication number
DK3468553T3
DK3468553T3 DK17810987.2T DK17810987T DK3468553T3 DK 3468553 T3 DK3468553 T3 DK 3468553T3 DK 17810987 T DK17810987 T DK 17810987T DK 3468553 T3 DK3468553 T3 DK 3468553T3
Authority
DK
Denmark
Prior art keywords
andrographolide
multiple sclerosis
progressive forms
treats
treats progressive
Prior art date
Application number
DK17810987.2T
Other languages
Danish (da)
English (en)
Inventor
Juan O Hancke
Original Assignee
Innobioscience Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innobioscience Llc filed Critical Innobioscience Llc
Application granted granted Critical
Publication of DK3468553T3 publication Critical patent/DK3468553T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK17810987.2T 2016-06-08 2017-06-08 Andrographolid behandler progressive former for multipel sklerose DK3468553T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662347218P 2016-06-08 2016-06-08
PCT/US2017/036463 WO2017214346A1 (en) 2016-06-08 2017-06-08 Andrographolide treats progressive forms of multiple sclerosis

Publications (1)

Publication Number Publication Date
DK3468553T3 true DK3468553T3 (da) 2023-07-03

Family

ID=60578163

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17810987.2T DK3468553T3 (da) 2016-06-08 2017-06-08 Andrographolid behandler progressive former for multipel sklerose

Country Status (8)

Country Link
US (1) US10722492B2 (enExample)
EP (1) EP3468553B1 (enExample)
JP (2) JP6928963B2 (enExample)
CN (1) CN109562097B (enExample)
CA (1) CA3026770C (enExample)
DK (1) DK3468553T3 (enExample)
MX (1) MX386393B (enExample)
WO (1) WO2017214346A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019126759A1 (en) * 2017-12-22 2019-06-27 Convelo Therapeutics, Inc. Compounds and methods of promoting myelination
CN109223770A (zh) * 2018-11-14 2019-01-18 株洲千金药业股份有限公司 一种具有镇痛作用的化合物及其在制备镇痛药物中的应用
CN109293607A (zh) * 2018-11-14 2019-02-01 株洲千金药业股份有限公司 一种具有抗炎作用的化合物及其在制备抗炎药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060057107A1 (en) * 2001-12-21 2006-03-16 Shaked Ze Ev Combination treatment for multiple sclerosis
MXPA06008738A (es) * 2004-02-03 2008-03-07 Univ Austral De Chile Composicion que comprende una mezcla de lavadnos diterpenicos, de un extracto de planta andrographis paniculata, seleccionado de andrografolido, 14-deoxiandrografolido y neoandrografolido; sus usos.
EP2670406B1 (en) 2011-12-21 2015-09-02 InnoBioscience, LLC Combination therapy with interferon beta and andrographolides for multiple sclerosis

Also Published As

Publication number Publication date
MX2018015208A (es) 2019-09-19
EP3468553A4 (en) 2020-02-12
US20190083458A1 (en) 2019-03-21
CA3026770C (en) 2024-05-28
JP6928963B2 (ja) 2021-09-01
JP2019517550A (ja) 2019-06-24
EP3468553B1 (en) 2023-05-24
WO2017214346A1 (en) 2017-12-14
JP2021165304A (ja) 2021-10-14
EP3468553A1 (en) 2019-04-17
CN109562097B (zh) 2022-06-07
MX386393B (es) 2025-03-18
CA3026770A1 (en) 2017-12-14
CN109562097A (zh) 2019-04-02
US10722492B2 (en) 2020-07-28

Similar Documents

Publication Publication Date Title
IL263586B (en) Inhibitors of the menin-mll interaction
IL264458B (en) Cannabis composition
EP3563646C0 (en) HIGH VOLTAGE INDUCTIVE ADDER
HUE047477T2 (hu) Palbociclib szilárd dózisformái
EP3445750A4 (en) THERAPEUTIC COMPOUNDS
IL263050B (en) Derivatives of sobetirome
DK3453721T3 (da) Process of manufacture of annexin v
EP3406336A4 (en) NANO FOIL OF CORE CASE STRUCTURE TYPE
EP3360010A4 (en) BI PHOTONS WITH VOTABLE SOURCE
DK3283210T3 (da) Fremgangsmåde
LT3307267T (lt) Išsėtinės sklerozės gydymas
EP3458037A4 (en) FLUORCHEMICAL TARGETED THERAPIES
LT3464336T (lt) Junginiai
DK3416923T3 (da) Gipsplade
ES2784531R1 (es) Metodos para producir un compuesto de elastomero y compuestos de elastomero
IL254502A0 (en) Solid forms of menaquinols
EP3338088A4 (en) BIOMARKER FOR CORONARY DISEASE
IL263838A (en) Phospholipid compositions
EP3532057A4 (en) KALLICREIN INHIBITOR PRODUCTS
DK3374357T3 (da) Disubstituerede diaryloxybenzoheterodiazol-forbindelser
HUE056928T2 (hu) Új vegyületek
EP3446199A4 (en) CONTEXT MODIFICATION OF INQUIRIES
DK3429976T3 (da) Gipsplade
EP3402328A4 (en) FISH FALL RUNNER
EP3471729A4 (en) THERAPEUTIC CONNECTIONS